Get the Stockscreener App
4.24
0.93%
-0.04
After Hours:
4.24
Avita Medical Inc stock is traded at $4.24, with a volume of 111.10K.
It is down -0.93% in the last 24 hours and up +14.29% over the past month.
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$4.28
Open:
$4.32
24h Volume:
111.10K
Relative Volume:
0.50
Market Cap:
$130.49M
Revenue:
$71.61M
Net Income/Loss:
$-48.59M
P/E Ratio:
-2.4215
EPS:
-1.751
Net Cash Flow:
$-32.88M
1W Performance:
-2.08%
1M Performance:
+14.29%
6M Performance:
+21.14%
1Y Performance:
-53.96%
1-Day Range:
$4.175
$4.36
1-Week Range:
$4.11
$4.565
52-Week Range:
$3.22
$9.845
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
4.24 | 131.72M | 71.61M | -48.59M | -32.88M | -1.751 |
ABT
Abbott Laboratories
|
87.17 | 152.48B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
295.25 | 111.40B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
77.79 | 100.53B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
55.98 | 84.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
82.91 | 48.04B | 6.30B | 1.07B | 1.34B | 1.8406 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-05-26 | Initiated | Northland Capital | Outperform |
| Nov-20-25 | Upgrade | BTIG Research | Sell → Neutral |
| Aug-08-25 | Downgrade | BTIG Research | Neutral → Sell |
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
AVITA Medical appoints Cary Vance as permanent CEO - MSN
AVITA Medical Appoints Cary Vance as Permanent CEO and Jan Stern Reed as Board Chair to Drive Growth in Acute Wound Care Solutions - Minichart
Avita Medical (NASDAQ:RCEL) Stock Rating Lowered by Wall Street Zen - MarketBeat
AVITA Medical wins BARDA contract worth up to $25.5M - MSN
Avita Medical Names Cary Vance Permanent CEO, Reshapes Board - TipRanks
Cary Vance becomes AVITA Medical (NASDAQ: RCEL) CEO as Board elevates Jan Stern Reed to Chair - Stock Titan
AVITA Medical Names Cary Vance as Chief Executive Officer - Investing News Network
AVITA Medical names Cary Vance as permanent CEO - Investing.com
AVITA Medical names Cary Vance as permanent CEO By Investing.com - Investing.com Canada
After 6 months as interim CEO, Cary Vance gets AVITA's top job - Stock Titan
RCEL Stock Price, Quote & Chart | AVITA MEDICAL INC (NASDAQ:RCEL) - ChartMill
Avita Medical (RCEL) Secures Certification for Recell Go in Aust - GuruFocus
AVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GO - Investing News Network
AVITA Medical gains regulatory clearance for RECELL GO in Australia By Investing.com - Investing.com Canada
Burn care tool cleared for sale in Australia and New Zealand - Stock Titan
Why this ASX healthcare stock is surging while the market sinks on Middle East fears - MSN
AVITA Medical appoints Cary Vance as interim CEO - MSN
Avita Medical (RCEL) upgraded to buy: Here's what you should know - MSN
Avita signals revenue recovery with $70M–$74M 2025 outlook following reimbursement clarity - MSN
AVITA Medical to Announce First Quarter 2026 Financial Results - Investing News Network
AVITA Medical schedules May 14 earnings release, 1:30 p.m. call - Stock Titan
Guess which ASX All Ords healthcare share is jumping 11% on big European news - MSN
Is Avita Medical (RCEL) stock under bearish pressure | Q4 2025: Below ExpectationsCyclicality - Cổng thông tin điện tử tỉnh Tây Ninh
Board pay, director equity and warrants on AVITA Medical (NASDAQ: RCEL) 2026 ballot - Stock Titan
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical ... - Bluefield Daily Telegraph
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc.RCEL - ChartMill
Is Avita Medical (RCEL) stock overpriced relative to performance (Trades Higher) 2026-04-18 - Cổng thông tin điện tử Tỉnh Sơn La
TD Cowen Maintains Avita Medical(RCEL.US) With Buy Rating, Maintains Target Price $5.5 - 富途牛牛
ALERT: Price-sensitive ASX Announcement for AVH - intelligentinvestor.com.au
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.93%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):